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Understanding the aetiology of male breast cancer could
contribute towards an understanding of the disease among women.
The principal findings in previous studies were that male breast
cancer is more common among unmarried and childless men as
well as among those with gynecomastia.
The collective epidemiological evidence suggests that increased
oestrogen production and/or sexual drive-reducing endocrine
conditions could be the underlying hormonal pattern in male
breast cancer (Rose, 1988; Thomas et al, 1992). This is supported
by a retrospective cohort study in Denmark indicating an excess
occurrence of breast cancer among men with cirrhosis, who are
considered as having elevated values of blood oestrogens
(Sorensen et al, 1998), in keeping with the role of oestrogens in
female breast cancer (Toniolo et al, 1995; Collaborative Group on
Hormonal Factors in Breast Cancer, 1996, 1997; Adami et al,
1998; Hankinson et al, 1998).
We have undertaken a case-control study of male breast cancer
in Athens, Greece, with the following objectives: (a) to evaluate
the role of sexual drive, as indicated by the frequency of orgasms,
whether through intercourse or other means (Mantzoros et al,
1995; McClellan and Markham, 1999); (b) to assess whether
tobacco smoking may be inversely related to risk since tobacco
smoking adversely affects oestrogenicity (Michnovicz and
Fishman, 1990); (c) to examine whether first born boys are at
higher risk than later born boys, oestrogen levels during pregnancy
being higher among primiparous than among multiparous women
(Bernstein et al, 1986; Panagiotopoulou et al, 1990; Potischman
and Troisi, 1999).
During a two-year period (1996–1997) 55 new cases of breast
cancer were diagnosed among male permanent residents of
Greater Athens (male population around 2 million). About half of
these cases were diagnosed and treated in the two major cancer
hospitals of Greater Athens ‘Agios Savas’ and ‘Metaxas’ and all
23 histologically confirmed cases were included in this study.
For every male patient with breast cancer we attempted to
identify four controls matching for age (± five years), two visitors
in the same hospital and two injured patients in the single trauma
hospital of Athens (KAT). All controls had to be free from a
history of cancer at any site and be permanent residents of Greater
Athens. No second visitor control was identified for eight cancer
cases, whereas eight potential controls (four hospital visitors and
four trauma patients) refused to be interviewed. Thus, the study
included 23 male breast cancer patients and 76 controls. Each case
had at least two controls. All cases and controls were interviewed
by a board qualified surgeon (G.G.), who, unavoidably, was aware
of the case or control status of each subject. The questionnaire
covered sociodemographic and life-style characteristics, as well as
regular use of medications (excluding dietary supplements). In
addition, all 99 participants were asked to indicate average
frequency of orgasms per month, during different periods of their
life.
As visitor controls and trauma patients were similar with respect
to all the studied variables, the 76 controls were combined in a
single group and compared with the 23 cases. Univariate analyses
showed that sibship size was positively associated with birth order,
as were alcohol consumption, tobacco smoking and coffee
drinking. However, mutual adjustment, as necessary, through
logistic regression, did not notably change the relevant effect
estimates. Given the small number of cases and the apparent lack
of confounding we decided to present simple, straightforward
analyses, using modelling only when there was a need to
document absence of substantial confounding.
Cases and controls showed similar distributions with respect to
age, family status, number of own children, weight at diagnosis
and sibship size. In contrast, there was a statistically significant
inverse association between birth order and breast cancer risk.
Sibship size did not appreciably confound the association between
birth order and breast cancer (Table 1). No evidence was found for
an effect on breast cancer risk of any occupational exposure,
although the numbers were small (Table 2).
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One case and four controls indicated that they were primarily
homosexual, essentially similar proportions. Table 3 shows the
number of reported orgasms per month at ages 20–29 years (all
subjects) and 50–59 years (those aged 50 and over). There is an
inverse association between frequency of orgasm and male breast
cancer risk, stronger and highly significant at age 50–59 years.
In Table 4, the results concerning life-style variables are
presented. Coffee and alcohol intake show no relation to risk. On
the contrary, tobacco smoking is inversely associated with this
risk. Several drugs were reported by participants as being regularly
taken and for two, results are shown in Table 4. Aspirin was the
regularly taken drug most frequently reported and intake of more
than seven aspirin tablets per month was inversely (but not signif-
icantly) associated with risk. The statistically significant positive
association with tranquillizer intake is probably a chance finding
given the multiple comparisons. Three cases and two controls
reported longstanding gynaecomastia, an OR of 5.55 (95% CI
0.58–69.09). The results remained essentially unchanged when
several multiple logistic regression models were examined (data
not shown).
There have been at least two much larger studies of male breast
cancer (Thomas et al, 1992; Hsing et al, 1998) and several others
with statistical power similar to that of ours (Mabuchi et al, 1985;
Casagrande et al, 1988; Lenfant-Pejovic et al, 1990; D’Avanzo
and La Vecchia, 1995; Stenlund and Floderus, 1997). In the
present small study however, we have examined two new
hypotheses and for both, plausible and statistically significant
findings were generated. Frequency of orgasms, possibly because
its validation as a correlate of DHT, the hormone which probably
drives male sexual behaviour, is only recent (Mantzoros et al,
Table 1 Distribution of 23 breast cancer cases and 76 age-matched controls by sociodemographic variables
Variable Cases Controls Odds ratio P value
(n)( n) (95% CI)a 2-tailedb
Age (years)
≤ 49 2 12 Matched variable 0.42
50–59 4 14
60–69 8 24
≥ 70 9 26
Sibship size
≤ 2 13 28 Baseline 0.15
≥ 3 10 48 0.45 (0.15–1.28)
Birth order
1 10 18 Baseline 0.02
2 7 17 0.74 (0.19–2.77)
≥ 3 6 41 0.26 (0.07–0.96)
Marital status
Married/widowed 21 72 Baseline 0.92
Single/divorced 2 4 1.71 (0.14–12.87)
Number of children
0 4 12 Baseline 0.89 
≥ 1 19 64 0.89 (0.23–4.24)
Weight (kg)
≤ 64 2 12 Baseline 0.89
65–69 5 9 3.33 (0.40–40.90)
70–74 6 16 2.25 (0.32–26.07)
≥ 75–79 10 39 1.54 (0.27–16.26)
a95% Confidence Intervals (CI) calculated using exact methods. bFrom χ 2 with one degree of freedom for 2*2 tables with Yates’ correction; and from
χ 2 for trend for 2*k tables.
Table 2 Distribution of 23 breast cancer cases and 76 age-matched controls by history of occupational exposures
Variable Cases Controls Odds ratio P value
(n)( n) (95% CI)a 2-tailed
Ionizing radiation
No 23 75 Baseline 0.41
Yes 0 1 Undefined
Pesticides
No 15 48 Baseline 0.95
Yes 8 28 0.91 (0.30–2.66)
Oil products
No 20 67 Baseline 0.83
Yes 3 9 1.12 (0.18–5.06)
Elevated temperature
No 17 54 Baseline 1.00
Yes 6 22 0.87 (0.25–2.71)
Dust (any type)
No 15 58 Baseline 0.43
Yes 8 18 1.72 (0.54–5.18)
a95% Confidence Intervals (CI) calculated using exact methods.1236 E Petridou et al
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1995). Also, the association with birth order (Hsieh et al, 1991;
Adebamowo and Adekunle, 1999) and its possible mechanism
(Bernstein et al, 1986; Panagiotopoulou, 1990) have been pre-
viously evaluated only among women.
Despite the small size, the present study has some methodo-
logical strengths. Although the interviews were not blind to case-
control status, they were conducted by the same medically
qualified person in-hospital, and there were few refusals. Both
visitor and trauma patient controls showed similar findings, as in
earlier studies in Greece (Kalapothaki et al, 1993). Also, the estab-
lished risk factors for male breast cancer, namely an increased risk
among men who were single, childless, or with gynaecomastia
were confirmed in this study, although none of these associations
was statistically significant perhaps because of the small numbers.
Many previous studies have indicated that male breast cancer
is more common among men who are single or have few or
no children (Schottenfeld et al, 1963; Casagrande et al, 1988;
Lenfant-Pejovic et al, 1990; Thomas et al, 1992; D’Avanzo and
La Vecchia, 1995; Cocco et al, 1998). These findings have been
assumed to reflect reduced sexual drive (Rose, 1988; Thomas et al,
1992). Our results support this assumption, in that men with breast
cancer had fewer orgasms than control participants at comparable
ages. The findings could not be explained by confounding and it is
unlikely due to bias; a link between reduced libido and male breast
cancer has not been generally suspected by the public.
The inverse association between tobacco smoking and male
breast cancer risk is not implausible given the evidence that
smoking in men (as well as in women) tends to produce hypo-
oestrogenic effects (Michnovicz and Fishman, 1990). An inverse,
but statistically non-significant, association between cigarette
smoking and risk of male breast cancer can also be seen in the data
of Mabuchi et al (1985) and Casagrande et al (1988).
Ever since Bernstein et al (1986) and Panagiotopoulou et al
(1990) reported high levels of oestrogens in first rather than
Table 3 Distribution of 23 breast cancer cases and 76 age-matched controls by number of orgasms per month at the age of around 25 (all subjects) and
around 50 (subjects 50 years or older)
Number of Cases Controls Odds ratio P value
orgasms per (n)( n) (95% CI)a 2-tailedb
month
Men 20–29 years 0.08
≤ 6 11 18 Baseline
7–13 5 27 0.30 (0.09–1.00)
≥ 14 7 31 0.37 (0.12–1.11)
Men 50+ years 0.004
≤ 6 13 14 Baseline
7–13 6 37 0.18 (0.06–0.53)
≥ 14 2 13 0.17 (0.03–0.81)
a95% Confidence Intervals (CI) calculated using exact methods. bFrom χ 2 for trend for 2*k tables.
Table 4 Distribution of 23 breast cancer cases and 76 age-matched controls by lifestyle variables and regular use of specific medicines
Category Cases Controls Odds ratio P value
(n)( n) (95% CI)a 2-tailedb
Lifestyle
Smoking
Never 9 20 Baseline 0.03
Ex-smoker 11 25 0.98 (0.30–3.25)
Smoker 3 31 0.22 (0.03–1.02)
Coffee drinking
No 6 14 Baseline 0.62
Yes 17 62 0.64 (0.19–2.36)
Alcohol consumption
None 4 10 Baseline 0.12
Occasional drinker (< 7/week) 12 26 1.15 (0.26–6.07)
Regular drinker (≥ 7 week) 7 40 0.44 (0.09–2.48)
Regular use of medicines
Aspirin tablets/month
0 15 44 Baseline 0.39
1–6 7 24 0.86 (0.26–2.62)
≥ 7 1 8 0.37 (0.01–3.18)
Tranquillizer(s)
No 17 72 Baseline 0.01
Yes 6 4 6.35 (1.31–33.35)
Medical condition
Gynaecomastia
No 20 74 Baseline 0.15
Yes 3 2 5.55 (0.58–69.09)
a95% Confidence Intervals (CI) calculated using exact methods. bFrom χ 2 with one degree of freedom for 2*2 tables with Yates’ correction;
and from χ 2 for trend for 2*k tables.Male breast cancer risk 1237
British Journal of Cancer (2000) 83(9), 1234–1237 © 2000 Cancer Research Campaign
subsequent pregnancies, the hypothesis of prenatal origin of breast
cancer (Trichopoulos and Lipman, 1992) has gained more credi-
bility (Hsieh et al, 1991; Adebamowo and Adekunle, 1999). Our
results appear to provide some evidence for prenatal or early life
influences on male breast cancer risk, as well as a link with oestro-
gens.
Like others, we found no evidence of occupational risks
(Mabuchi et al, 1985; Lenfant-Pejovic et al, 1990; Rosenbaum
et al, 1994; Stenlund and Floderus, 1997), or that hot work places
increased risk as has been suggested (Mabuchi et al, 1985). Our
findings on history of regular drug use are also essentially
negative.
This study provides evidence that reduced sexual drive is
associated with male breast cancer, whereas anti-oestrogenic
influences may reduce this risk. If DHT is indeed the principal
hormone responsible for male sexual behaviour (Mantzoros et al,
1995; McClellan and Markham, 1999), and since serum levels of
testosterone, as well as oestradiol, have been found to be higher
among cases with male breast cancer than among controls
(Rose, 1988), it seems reasonable to speculate that reduced
conversion of testosterone to DHT underlies at least one stage of
the pathogenesis of male breast cancer.
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